A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia

Clinical trial NCT03914625 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03914625
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

B Acute Lymphoblastic Leukemia B Lymphoblastic Lymphoma Down Syndrome

Start date: 2019-07-03
Primary completion: 2027-09-30
Enrollment: 6720

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.